Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Poland

Marie Skłodowska-Curie Action · Running

MAP-ID Multilevel approaches to understanding chronic inflammatory diseases.

Coordinator
Uniwersytet Jagiellonski, Poland
Runs
1 April 2025 to 31 March 2030
Status
Running
EU funding
€1.7m
Total cost
—
Partners
21 organisations in 10 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101179116

What the project is doing

In the project's own words, from its summary on CORDIS.

The MAP-ID project aims to deliver an East-West Europe-integrating training programme for PhD students, focused on tackling one of the most challenging, complex, and therapeutically unmet problems which are chronic inflammatory diseases. MAP-ID will train chronic inflammation-oriented researchers to become leaders in the field in regional, national, and international arenas. Within the doctoral programme, 13 DCs will conduct their research under the supervision of prominent specialists from the Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University in Poland (JU), in collaboration with international partner academic institutions and biotech companies.

MAP-ID focuses on multilevel approaches to understanding chronic inflammatory diseases, including infectious, autoimmune, allergic disorders, and cancer. To achieve this goal, the programme will establish and strengthen ties and collaborations between JU and top Universities and non-academic partners in Europe and beyond. MAP-ID aims to foster interdisciplinary research spanning molecular, cell, and structural biology, biophysics, chemistry, pharmaceutical sciences, and bioinformatics with a significant contribution of OMICS data sets.

The training will give the DCs a detailed insight into the strategies and mechanisms required to contribute to growth in the sector of academic and industrial research related to chronic inflammatory disease research and development. The training will include courses conducted by both host institution researchers and visiting scientists from world-leading Universities and companies. Some of the courses offered for DCs, created specifically for MAP-ID, will be accessible to other JU researchers, enriching the learning resources available to them.

Therefore, the MAP-ID will have a significant impact on the JU community and its public image, enabling JU to strengthen its position as a leader in chronic inflammation-related research in central Europe.

Topics

Who is involved

OrganisationCityCountryRole
Uniwersytet JagiellonskiKrakowPolandCoordinator
Medizinische Universitat GrazGrazAustriaAssociatedpartner
Katholieke Universiteit LeuvenLeuvenBelgiumAssociatedpartner
Universitat ZurichZurichSwitzerlandAssociatedpartner
PerioTrap Pharmaceuticals GmbHHalleGermanyAssociatedpartner
Fundacio Institut D'investigacio Biomedica De BellvitgeL'Hospitalet De LlobregatSpainAssociatedpartner
Fundacio Universitaria BalmesVic BarcelonaSpainAssociatedpartner
Universita Degli Studi Di PaviaPaviaItalyAssociatedpartner
Universita Degli Studi Di Roma La SapienzaRomaItalyAssociatedpartner
Academisch Ziekenhuis GroningenGroningenNetherlandsAssociatedpartner
Bgi Tech Solutions (poland) Sp. Z O.o.WarszawaPolandAssociatedpartner
BacteromicWarsawPolandAssociatedpartner
Polski Bank Komorek Macierzystych S.a.WarszawaPolandAssociatedpartner
Ryvu Therapeutics S.A.KrakówPolandAssociatedpartner
Wpd Pharmaceuticals Spolka Z Ograniczona OdpowiedzialnosciaWarszawaPolandAssociatedpartner
intoDNA S.A.KrakówPolandAssociatedpartner
Cambridge Protein Works LimitedCambridgeUnited KingdomAssociatedpartner
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomAssociatedpartner
Board of Regents of Nevada System of Higher EducationRenoUnited StatesAssociatedpartner
Virginia Commonwealth UniversityRichmond, VAUnited StatesAssociatedpartner
West Virginia UniversityMorgantownUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI